Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is EMPAGLIFLOZIN, with a corresponding US DMF Number 33545.
Remarkably, this DMF maintains an Active status since its submission on March 25, 2019, highlighting commitment to regulatory compliance.